{"entity":{"type":"insider","cik":"0001820036","url":"/insider/0001820036","json_url":"/insider/0001820036.json","name":"GRAHAM RICHARD A","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":14,"first":"2020-12-16","last":"2023-11-16","span_basis":"filed_date"},"name_variants":[{"name":"GRAHAM RICHARD A","source":"filing","n_filings":14,"first_seen":"2020-12-16","last_seen":"2023-11-16"}],"transactions":[{"id":8127804,"accession":"0001415889-23-015228","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-015228","line_url":"/filing/0001415889-23-015228#line-1","is_derivative":false,"issuer_cik":"0001583107","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001583107","owner_cik":"0001820036","owner_name":"GRAHAM RICHARD A","owner_display_name":"GRAHAM RICHARD A","owner_url":"/insider/0001820036","role":"Officer (SVP, RESEARCH & DEVELOPMENT)","role_mark":"O","role_mark_label":"Officer (SVP, RESEARCH & DEVELOPMENT)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, RESEARCH & DEVELOPMENT","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2482.0,"shares_display":"2,482","price_per_share":10.22,"price_display":"10.22","price_state":"stated","total_value":25366.04,"total_display":"25,366.04","total_whole":"25,366","shares_owned_after":346839.0,"shares_owned_after_display":"346,839","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-14","filed_date":"2023-11-16","scope":"insider"},{"id":8167172,"accession":"0001415889-23-014412","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-014412","line_url":"/filing/0001415889-23-014412#line-1","is_derivative":false,"issuer_cik":"0001583107","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001583107","owner_cik":"0001820036","owner_name":"GRAHAM RICHARD A","owner_display_name":"GRAHAM RICHARD A","owner_url":"/insider/0001820036","role":"Officer (SVP, RESEARCH & DEVELOPMENT)","role_mark":"O","role_mark_label":"Officer (SVP, RESEARCH & DEVELOPMENT)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, RESEARCH & DEVELOPMENT","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2482.0,"shares_display":"2,482","price_per_share":9.03,"price_display":"9.03","price_state":"stated","total_value":22412.46,"total_display":"22,412.46","total_whole":"22,412","shares_owned_after":334321.0,"shares_owned_after_display":"334,321","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-16","filed_date":"2023-10-18","scope":"insider"},{"id":8637759,"accession":"0001415889-23-013342","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-013342","line_url":"/filing/0001415889-23-013342#line-1","is_derivative":false,"issuer_cik":"0001583107","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001583107","owner_cik":"0001820036","owner_name":"GRAHAM RICHARD A","owner_display_name":"GRAHAM RICHARD A","owner_url":"/insider/0001820036","role":"Officer (SVP, RESEARCH & DEVELOPMENT)","role_mark":"O","role_mark_label":"Officer (SVP, RESEARCH & DEVELOPMENT)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, RESEARCH & DEVELOPMENT","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2482.0,"shares_display":"2,482","price_per_share":9.89,"price_display":"9.89","price_state":"stated","total_value":24546.98,"total_display":"24,546.98","total_whole":"24,547","shares_owned_after":336803.0,"shares_owned_after_display":"336,803","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-14","filed_date":"2023-09-18","scope":"insider"},{"id":8764080,"accession":"0001415889-23-012271","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-012271","line_url":"/filing/0001415889-23-012271#line-1","is_derivative":false,"issuer_cik":"0001583107","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001583107","owner_cik":"0001820036","owner_name":"GRAHAM RICHARD A","owner_display_name":"GRAHAM RICHARD A","owner_url":"/insider/0001820036","role":"Officer (SVP, RESEARCH & DEVELOPMENT)","role_mark":"O","role_mark_label":"Officer (SVP, RESEARCH & DEVELOPMENT)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, RESEARCH & DEVELOPMENT","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2322.0,"shares_display":"2,322","price_per_share":9.99,"price_display":"9.99","price_state":"stated","total_value":23196.78,"total_display":"23,196.78","total_whole":"23,197","shares_owned_after":349746.0,"shares_owned_after_display":"349,746","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-11","filed_date":"2023-08-15","scope":"insider"},{"id":8231926,"accession":"0001415889-23-011244","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-011244","line_url":"/filing/0001415889-23-011244#line-1","is_derivative":false,"issuer_cik":"0001583107","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001583107","owner_cik":"0001820036","owner_name":"GRAHAM RICHARD A","owner_display_name":"GRAHAM RICHARD A","owner_url":"/insider/0001820036","role":"Officer (SVP, RESEARCH & DEVELOPMENT)","role_mark":"O","role_mark_label":"Officer (SVP, RESEARCH & DEVELOPMENT)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, RESEARCH & DEVELOPMENT","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2322.0,"shares_display":"2,322","price_per_share":9.84,"price_display":"9.84","price_state":"stated","total_value":22848.48,"total_display":"22,848.48","total_whole":"22,848","shares_owned_after":352068.0,"shares_owned_after_display":"352,068","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-14","filed_date":"2023-07-18","scope":"insider"},{"id":8637585,"accession":"0001415889-23-009963","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-009963","line_url":"/filing/0001415889-23-009963#line-1","is_derivative":false,"issuer_cik":"0001583107","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001583107","owner_cik":"0001820036","owner_name":"GRAHAM RICHARD A","owner_display_name":"GRAHAM RICHARD A","owner_url":"/insider/0001820036","role":"Officer (SVP, RESEARCH & DEVELOPMENT)","role_mark":"O","role_mark_label":"Officer (SVP, RESEARCH & DEVELOPMENT)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, RESEARCH & DEVELOPMENT","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2322.0,"shares_display":"2,322","price_per_share":10.69,"price_display":"10.69","price_state":"stated","total_value":24822.18,"total_display":"24,822.18","total_whole":"24,822","shares_owned_after":354390.0,"shares_owned_after_display":"354,390","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-14","filed_date":"2023-06-16","scope":"insider"},{"id":8028747,"accession":"0001415889-23-008228","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-008228","line_url":"/filing/0001415889-23-008228#line-1","is_derivative":false,"issuer_cik":"0001583107","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001583107","owner_cik":"0001820036","owner_name":"GRAHAM RICHARD A","owner_display_name":"GRAHAM RICHARD A","owner_url":"/insider/0001820036","role":"Officer (SVP, RESEARCH & DEVELOPMENT)","role_mark":"O","role_mark_label":"Officer (SVP, RESEARCH & DEVELOPMENT)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, RESEARCH & DEVELOPMENT","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2322.0,"shares_display":"2,322","price_per_share":11.26,"price_display":"11.26","price_state":"stated","total_value":26145.72,"total_display":"26,145.72","total_whole":"26,146","shares_owned_after":367172.0,"shares_owned_after_display":"367,172","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-15","filed_date":"2023-05-17","scope":"insider"},{"id":8684802,"accession":"0001415889-23-006620","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-006620","line_url":"/filing/0001415889-23-006620#line-1","is_derivative":false,"issuer_cik":"0001583107","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001583107","owner_cik":"0001820036","owner_name":"GRAHAM RICHARD A","owner_display_name":"GRAHAM RICHARD A","owner_url":"/insider/0001820036","role":"Officer (SVP, RESEARCH & DEVELOPMENT)","role_mark":"O","role_mark_label":"Officer (SVP, RESEARCH & DEVELOPMENT)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, RESEARCH & DEVELOPMENT","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2323.0,"shares_display":"2,323","price_per_share":11.88,"price_display":"11.88","price_state":"stated","total_value":27597.24,"total_display":"27,597.24","total_whole":"27,597","shares_owned_after":369494.0,"shares_owned_after_display":"369,494","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-14","filed_date":"2023-04-18","scope":"insider"},{"id":8516380,"accession":"0001415889-23-005044","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-005044","line_url":"/filing/0001415889-23-005044#line-1","is_derivative":false,"issuer_cik":"0001583107","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001583107","owner_cik":"0001820036","owner_name":"GRAHAM RICHARD A","owner_display_name":"GRAHAM RICHARD A","owner_url":"/insider/0001820036","role":"Officer (SVP, RESEARCH & DEVELOPMENT)","role_mark":"O","role_mark_label":"Officer (SVP, RESEARCH & DEVELOPMENT)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, RESEARCH & DEVELOPMENT","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2323.0,"shares_display":"2,323","price_per_share":10.32,"price_display":"10.32","price_state":"stated","total_value":23973.36,"total_display":"23,973.36","total_whole":"23,973","shares_owned_after":371817.0,"shares_owned_after_display":"371,817","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-14","filed_date":"2023-03-16","scope":"insider"},{"id":8612714,"accession":"0001415889-23-004552","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-004552","line_url":"/filing/0001415889-23-004552#line-1","is_derivative":false,"issuer_cik":"0001583107","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001583107","owner_cik":"0001820036","owner_name":"GRAHAM RICHARD A","owner_display_name":"GRAHAM RICHARD A","owner_url":"/insider/0001820036","role":"Officer (SVP, RESEARCH & DEVELOPMENT)","role_mark":"O","role_mark_label":"Officer (SVP, RESEARCH & DEVELOPMENT)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, RESEARCH & DEVELOPMENT","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2323.0,"shares_display":"2,323","price_per_share":10.05,"price_display":"10.05","price_state":"stated","total_value":23346.15,"total_display":"23,346.15","total_whole":"23,346","shares_owned_after":374140.0,"shares_owned_after_display":"374,140","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-06","filed_date":"2023-03-08","scope":"insider"},{"id":6326946,"accession":"0001415889-22-012077","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-012077","line_url":"/filing/0001415889-22-012077#line-1","is_derivative":false,"issuer_cik":"0001583107","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001583107","owner_cik":"0001820036","owner_name":"GRAHAM RICHARD A","owner_display_name":"GRAHAM RICHARD A","owner_url":"/insider/0001820036","role":"Officer (SVP, RESEARCH & DEVELOPMENT)","role_mark":"O","role_mark_label":"Officer (SVP, RESEARCH & DEVELOPMENT)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, RESEARCH & DEVELOPMENT","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2084.0,"shares_display":"2,084","price_per_share":10.73,"price_display":"10.73","price_state":"stated","total_value":22361.32,"total_display":"22,361.32","total_whole":"22,361","shares_owned_after":313520.0,"shares_owned_after_display":"313,520","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-01","filed_date":"2022-12-05","scope":"insider"},{"id":6757791,"accession":"0001415889-22-008835","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-008835","line_url":"/filing/0001415889-22-008835#line-1","is_derivative":false,"issuer_cik":"0001583107","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001583107","owner_cik":"0001820036","owner_name":"GRAHAM RICHARD A","owner_display_name":"GRAHAM RICHARD A","owner_url":"/insider/0001820036","role":"Officer (SVP, DEVELOPMENT)","role_mark":"O","role_mark_label":"Officer (SVP, DEVELOPMENT)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, DEVELOPMENT","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4906.0,"shares_display":"4,906","price_per_share":9.7105,"price_display":"9.71","price_state":"stated","total_value":47639.713,"total_display":"47,639.71","total_whole":"47,640","shares_owned_after":364745.0,"shares_owned_after_display":"364,745","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-16","filed_date":"2022-08-18","scope":"insider"},{"id":6115110,"accession":"0001415889-22-008512","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-008512","line_url":"/filing/0001415889-22-008512#line-1","is_derivative":false,"issuer_cik":"0001583107","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001583107","owner_cik":"0001820036","owner_name":"GRAHAM RICHARD A","owner_display_name":"GRAHAM RICHARD A","owner_url":"/insider/0001820036","role":"Officer (SVP, DEVELOPMENT)","role_mark":"O","role_mark_label":"Officer (SVP, DEVELOPMENT)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, DEVELOPMENT","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15086.0,"shares_display":"15,086","price_per_share":8.79,"price_display":"8.79","price_state":"stated","total_value":132605.94,"total_display":"132,605.94","total_whole":"132,606","shares_owned_after":369651.0,"shares_owned_after_display":"369,651","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-09","filed_date":"2022-08-11","scope":"insider"},{"id":2708636,"accession":"0001179110-20-012003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-012003","line_url":"/filing/0001179110-20-012003#line-1","is_derivative":false,"issuer_cik":"0001583107","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001583107","owner_cik":"0001820036","owner_name":"GRAHAM RICHARD A","owner_display_name":"GRAHAM RICHARD A","owner_url":"/insider/0001820036","role":"Officer (SVP, Development)","role_mark":"O","role_mark_label":"Officer (SVP, Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Development","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":19.4744,"price_display":"19.47","price_state":"stated","total_value":146058.0,"total_display":"146,058.00","total_whole":"146,058","shares_owned_after":123749.0,"shares_owned_after_display":"123,749","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-14","filed_date":"2020-12-16","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":14,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001583107","name":"Theravance Biopharma, Inc.","url":"/issuer/0001583107","role":"Officer (SVP, RESEARCH & DEVELOPMENT)","n_filings":14,"first_seen":"2020-12-16","last_seen":"2023-11-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001820036","retrieved_at":"2026-08-24T05:30:38+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}